- Home
- SNGX vs MTEK Comparison
SNGX vs MTEK Comparison
Compare SNGX & MTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- MTEK
- Stock Information
- Founded
- SNGX 1987
- MTEK 2008
- Country
- SNGX United States
- MTEK Israel
- Employees
- SNGX N/A
- MTEK N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- MTEK
- Sector
- SNGX Health Care
- MTEK
- Exchange
- SNGX Nasdaq
- MTEK Nasdaq
- Market Cap
- SNGX 13.8M
- MTEK 15.1M
- IPO Year
- SNGX 1987
- MTEK 2022
- Fundamental
- Price
- SNGX $1.34
- MTEK $1.44
- Analyst Decision
- SNGX Strong Buy
- MTEK
- Analyst Count
- SNGX 1
- MTEK 0
- Target Price
- SNGX $6.00
- MTEK N/A
- AVG Volume (30 Days)
- SNGX 697.0K
- MTEK 71.3K
- Earning Date
- SNGX 11-10-2025
- MTEK 09-26-2025
- Dividend Yield
- SNGX N/A
- MTEK N/A
- EPS Growth
- SNGX N/A
- MTEK N/A
- EPS
- SNGX N/A
- MTEK N/A
- Revenue
- SNGX N/A
- MTEK $3,375,716.00
- Revenue This Year
- SNGX N/A
- MTEK N/A
- Revenue Next Year
- SNGX N/A
- MTEK N/A
- P/E Ratio
- SNGX N/A
- MTEK N/A
- Revenue Growth
- SNGX N/A
- MTEK N/A
- 52 Week Low
- SNGX $1.09
- MTEK $1.42
- 52 Week High
- SNGX $6.23
- MTEK $6.47
- Technical
- Relative Strength Index (RSI)
- SNGX 34.06
- MTEK 30.00
- Support Level
- SNGX $1.54
- MTEK $1.63
- Resistance Level
- SNGX $1.61
- MTEK $1.80
- Average True Range (ATR)
- SNGX 0.10
- MTEK 0.14
- MACD
- SNGX 0.01
- MTEK 0.00
- Stochastic Oscillator
- SNGX 8.70
- MTEK 2.63
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About MTEK Maris-Tech Ltd.
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.